| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.008 |